Where will the money come from to include flosins in the list of free drugs for seniors? We asked Dr. Jaroslaw Frąckowiak, president of PEX PharmaSequence, about this.
The topic of flosins and their place on the 75+ reimbursement list, or S list (seniors), is an interesting one. Particularly if we take into account that phlazines are talked about as a breakthrough therapy. And at the moment, senior patients have to pay for these drugs.
It looks like the total amount of money spent annually by seniors on vlazines is roughly 67 million. Of this amount, 21.5 million are sub...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
